Search results
Results From The WOW.Com Content Network
Contact us; Contribute Help; ... Number of employees. 15,000: Parent: Sanofi: Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical ...
In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. [2] In 2023, the company’s seat in Forbes Global 2000 was 89.
The Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. [ 4 ] [ 5 ] The Sanofi–GSK COVID‑19 vaccine was approved for medical use in the European Union in November 2022.
The Pasteur Institute (French: Institut Pasteur, pronounced [ɛ̃stity pastœʁ]) is a French non-profit private foundation dedicated to the study of biology, micro-organisms, diseases, and vaccines. It is named after Louis Pasteur, who invented pasteurization and vaccines for anthrax and rabies. The institute was founded on 4 June 1887 and ...
It was created by Marcel Mérieux in 1897 under the name Institut Biologique Mérieux (Mérieux Biological Institute). The vaccine development branch of the institute was separated early on and is now part of Sanofi Pasteur. [1], [2], [3] The current name was changed in 2009 from Mérieux Alliance. [1] The holding is owned through the Mérieux ...
Fluzone is typically administered in a single dose by intramuscular injection; [20] an intradermal injection is also available. [21] It is presented as a 0.25 ml syringe for pediatric use, as a 0.5 ml syringe for adults and children, as a 0.5 ml vial for adults and children, and as a 5 ml vial for adults and children. [20]
The applicant for this medicinal product is Sanofi Pasteur. [226] Supemtek was approved for medical use in the European Union in November 2020. [146] [227] Australia authorised its first and cell-based vaccine in March 2021, based on an "eternal cell line" of a dog kidney. Because of the way it is produced, it produces better-matched vaccine ...
CEO, Sanofi. Term. September 2019-. Predecessor. Olivier Brandicourt. Children. 3. Paul Hudson (born 14 October 1967) [2] is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales. [3]